Sardalla, Emily L.
HRN: 21-32-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2024
CEFTRIAXONE 1G (VIAL)
01/06/2024
01/12/2024
IVTT
2g
OD
Cap-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes